EDGAR Filing Documents for 0001521536-13-000752

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001521536-13-000752

Filing Date

2013-09-05

Accepted

2013-09-04 17:41:29

Documents

Effectiveness Date

2013-09-05

Items

Item 06: Rule 506

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	7249
	Complete submission text file	0001521536-13-000752.txt		8484

Mailing Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632

Business Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201-608-5101

BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)